PharmaVoice

JULY 7, 2022

Precision BioSciences’ CEO discusses the company’s potentially groundbreaking cancer treatment.

264

264

Pharmacy Times

JULY 7, 2022

People have been taking probiotics to support digestive health for centuries, but researchers in the pulmonary field have turned their attention toward how microbiome science can be used to support the lungs.

132

132

PharmaVoice

JULY 7, 2022

Marc Kikuchi weighs in on the company’s plans to pump up its pipeline and sales in the coming years.

246

246

Pharmacy Times

JULY 7, 2022

Trauma informed care has had an impact on the public health spectrum for years, especially with what has happened on a global front.

131

131

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

JULY 7, 2022

Pfizer is still waiting for the green light to complete an acquisition of digital health company ResApp, a deal that looks even better now that its smartphone app for people with obstructive sleep apnoea (OSA) has been approved by the FDA. Brisbane, Australia-based ResApp has claimed a 510(k) clearance for SleepCheckRx as a prescription-only digital therapy in the software-as-a-medical device (SaMD) category, clearing the path for a commercial launch in the US.

FDA 106

FDA 106

Pharmacy Times

JULY 7, 2022

Survey results show 40% of health care leaders believe a lack of communication between prescribers and pharmacists is preventing the successful management of patients’ medications.

Communication 123

Communication 123

Pharmacy Times

JULY 7, 2022

The FDA approved a licensure request for Fluzone High-Dose Quadrivalent, Flublok Quadrivalent, and Fluzone Quadrivalent for use in the upcoming 2022-2023 flu season, providing influenza vaccination for adults 65 years of age and older.

Vaccines 123

Vaccines FDA 123

Pharmaceutical Technology

JULY 7, 2022

Genetic mutations, both germline and acquired, are behind a large proportion of the most debilitating and sometimes life-threatening human diseases. But scientists have struggled to find effective treatments for many of these diseases since the dawn of modern medicine. For many decades, investigators have been working on innovative therapeutic modalities known as cell and gene therapies, which use modified versions of the body’s own cellular and genetic material to treat and potentially cure the

FDA 98

FDA 98

Pharmacy Times

JULY 7, 2022

Patient Centered Care is what should be at the heart of a pharmacist's work.

Patient Care 123

Patient Care 123

Outsourcing Pharma

JULY 7, 2022

The health care system and analytics company are joining on the ASAP study, a program that constitutes a five-year commitment to advancing cancer solutions.

95

95

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JULY 7, 2022

The panel of experts explore the contribution provided by pharmacists in the treatment landscape of patients with HR-positive, HER2-negative breast cancer.

111

111

Pharmaceutical Technology

JULY 7, 2022

The US Food and Drug Administration (FDA) has granted priority review to Roche’s Biologics License Application (BLA) of Lunsumio (mosunetuzumab) to treat adults with relapsed or refractory (R/R) follicular lymphoma (FL). These patients should have received a minimum of two prior systemic therapies. A CD20xCD3 T-cell engaging bispecific antibody, Lunsumio can act on CD20 present on the B-cell surface and CD3 on the T-cell surface.

FDA 64

FDA 64

Pharmacy Times

JULY 7, 2022

McKesson ideaShare 2022 is taking place in Washington, DC, from July 7 through 10.

Independent Pharmacies 73

Independent Pharmacies 73

pharmaphorum

JULY 7, 2022

New data on Sarepta’s gene therapy for Duchenne muscular dystrophy (DMD) has gone a long way towards building confidence in its efficacy – but have introduced a concern about its safety. Updated results from several trials of SRP-9001 (delandistrogene moxeparvovec) revealed a wealth of positives, including functional benefits in patients with the muscle-wasting disease after one to fours years of follow-up, pointing to a durable effect of the gene therapy.

FDA 59

FDA 59

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JULY 7, 2022

After Bite is indicated for relieving itch from bug bites and other mild irritations.

65

65

PharmExec

JULY 7, 2022

Amidst lack of funding for women’s health research, industry must collaborate now to advance RMMH.

59

59

Pharmacy Times

JULY 7, 2022

Although treating mental health symptoms is essential, finding the time and energy for more appointments can be challenging for patients with cancer.

65

65

Board Vitals - Pharmacist

JULY 7, 2022

There are countless issues impacting the world of healthcare today. From disparities in care to the overall cost of treatments, healthcare providers such as physician assistants have their hands full in confronting these challenges when caring for their patients. In an effort to support the PAs of the future, BoardVitals launched its first PA School Scholarship.

Medical Schools 52

Medical Schools 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JULY 7, 2022

Brexpiprazole is indicated as an adjunctive therapy to antidepressants in adults with major depressive disorder and as a treatment in adults with schizophrenia.

65

65

DiversifyRx

JULY 7, 2022

Becoming a sports pharmacy is a great way to boost cash-based revenues along with working with people who are passionate about their health. . Where Sports Pharmacy All Started For Me. I sort of married into sports nutrition and training. While I was an average athlete myself, I married an All-American athlete who had a degree in kinesiology and was a personal trainer.

Independent Pharmacies 52

Independent Pharmacies Documentation Compounding 52

NF2 BioSolutions

JULY 7, 2022

My name is Nicole Miller, I am 29 years old and suffer from NF2. I got diagnosed when I was 16 years old. I currently work as a nurse in Ophthalmology clinic. I love my job as a nurse and going through many surgeries at a young age is what inspired me to take up my nurse training. The care I received throughout my clinic appointments and surgery was fantastic and knew I wanted to give something back to the NHS and help patients throughout their appointments and stays in hospital.

Hospitals 52

Hospitals 52

Pharmacy Friday Pearls

JULY 7, 2022

Download PDF. Introduction. Rapid sequence intubation (RSI) is a process whereby an induction agent and a neuromuscular blocking agent are given in rapid succession to facilitate endotracheal intubation The selection of a specific sedative depends on multiple factors: the clinical scenario, which includes patient factors (includes cardiorespiratory and neurologic status, allergies, comorbidity) and the clinician’s experience/training and institutional factors, as well as the characteristics of t

Hospitals 52

Hospitals 52

PharmExec

JULY 7, 2022

Restructuring and ensuring the right talent is in place can help life sciences industry push through latest downward spiral.

52

52

Pharmaceutical Commerce

JULY 7, 2022

Easing of Omicron restrictions in China played a role, association notes.

52

52

Outsourcing Pharma

JULY 7, 2022

The latest indepth report from the AI-centric analytics provider reveals nearly half of US cancer clinical studies enroll no Latino patient participants.

52

52

PharmExec

JULY 7, 2022

In episode 112, Nima Farzan, CEO of Kinnate, who was one of Pharmaceutical Executive’s Emerging Pharma Leaders in 2013, discusses how he’s successfully navigated his career path, from building a foundation in pharma to growing his expertise in biotech.

52

52

Pharmaceutical Technology

JULY 7, 2022

It is said that leaders become obsessed with legacy when the curtain begins to fall on their time in power – but leaders don’t write their own history. Although Tony Blair may want to be remembered for public sector reform, peace in Northern Ireland and a reduction in child poverty, any biography of the man will be dominated by the catastrophic consequences of his decision to support the US-led invasion of Iraq.

52

52

pharmaphorum

JULY 7, 2022

The rumour that Merck & Co is preparing to make a sizeable offer to buy cancer specialist Seagen won’t go away. The latest report – in the Wall Street Journal – says that “advanced talks” are underway that could lead to a $200-plus per share offer that would value Seagen at a massive $40 billion, $10 billion more than earlier estimates.

52

52

Pharmacy Times

JULY 7, 2022

Drs Moore and Dent discuss the impact of oral selective estrogen receptor degraders and modulators in the treatment for HR-positive, HER2-negative breast cancer.

50

50

Pharma Times

JULY 7, 2022

The British Heart Foundation’s project will accelerate the search for better prevention and treatment of diabetes

49

49

Pharmacy Times

JULY 7, 2022

Paxlovid treats COVID-19 in adults and children [12 years of age and older weighing at least 88 pounds (40 kg)] with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death.

Hospitals 123

Hospitals FDA 123

Pharma Times

JULY 7, 2022

The therapy is for moderate-to-severe atopic dermatitis in adult patients who are candidates for systemic treatment

49

49

Pharmaceutical Technology

JULY 7, 2022

Brii Biosciences and TSB Therapeutics have commercially launched a long-acting neutralising antibody therapy combination, amubarvimab/romlusevimab, for Covid-19 in China. The two non-competing SARS-CoV-2 monoclonal neutralising antibodies, amubarvimab and romlusevimab are obtained from convalesced Covid-19 patients. The company developed these antibodies in partnership with Tsinghua University and the 3rd People’s Hospital of Shenzhen.

Hospitals 105

Hospitals 105